COMMUNIQUÉS West-GlobeNewswire

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia
29/05/2026
Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psilocybin and MDMA [...]
Jyong Biotech CEO Outlines FDA Pathway and Global Strategy in PharmaBoardroom Live Interview
29/05/2026
New Taipei City, Taiwan, May 29, 2026 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company dedicated to the development and commercialization [...]
BioNexus Gene Lab Corp. Calls for Malaysia–China Biotechnology Cooperation to Move Beyond Trade into Co-Development
29/05/2026
KUALA LUMPUR, Malaysia, May 29, 2026 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (Nasdaq: BGLC) (“BioNexus” or the “Company”), a technology-focused company advancing innovation across biotechnology, precision [...]
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy
29/05/2026
EDAP Announces Corporate Name Change to FocalTherics ™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026 Company [...]
SkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial Officer
29/05/2026
Mission-critical appointment with extensive public company, multinational, and emerging growth experience as SkyAI advances its agentic finance platform Marks the latest step in the Company’s evolution as it continues [...]
At ASCO and EHA 2026, New Data Reinforce the Pivotal Role of clonoSEQ® MRD Testing Across Hematology Clinical Practice and Research
29/05/2026
Over 30 scientific presentations leverage clonoSEQ MRD testing to assess novel therapies and support MRD-guided patient care across blood cancers SEATTLE, May 29, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies [...]
PetMed Express, Inc. to Report Fourth Quarter and Fiscal Year 2026 Financial Results on Tuesday, June 2, 2026
29/05/2026
DELRAY BEACH, Fla., May 29, 2026 (GLOBE NEWSWIRE) -- PetMed Express, Inc., dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) today announced it will report financial results for the fourth quarter and fiscal [...]
Seer Files ITC Complaint Against Nanomics
29/05/2026
Seeks Exclusion Order Barring Importation of Infringing Proteonano Kits and Workstations REDWOOD CITY, Calif., May 29, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased [...]
Spectral Medical Announces PMA Submission to U.S. FDA for PMX
29/05/2026
TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced the [...]
Pharvaris to Present Clinical Data at the EAACI Annual Congress 2026
29/05/2026
ZUG, Switzerland, May 29, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living [...]
PICARD MEDICAL, INC. Issues Letter to Shareholders
29/05/2026
TUCSON, Ariz., May 29, 2026 (GLOBE NEWSWIRE) -- Picard Medical, Inc. (NYSE American: PMI) (the “Company” or “Picard Medical”), parent company of SynCardia Systems LLC, maker of the world’s first and only total [...]
Agios Provides Update on Phase 2b Trial of Tebapivat in Lower-Risk Myelodysplastic Syndromes
29/05/2026
Results did not meet predefined threshold to support further development in LR-MDS Tebapivat was well tolerated, with no new safety signals observed CAMBRIDGE, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Agios [...]
Sequana Medical Announces Presentation on Recompensation of Decompensated Cirrhosis Following alfapump® Placement at EASL Congress 2026
29/05/2026
Ghent, Belgium, May 29, 2026 (GLOBE NEWSWIRE) -- Post-hoc analysis from the POSEIDON study demonstrates long-term resolution of ascites and early signs of liver function recovery in over 20% of patients with alfapump in [...]
Gumitide Gummies Under Investigation: Examining Customer Complaints, Ingredients Claims and Serious Side Effects Risk
29/05/2026
Gumitide Gummies Scam or Legit: Apple Cider Vinegar and BHB Keto Weight Management Formula, Ingredients, Results, and Refund Terms Explained Largo, FL, May 28, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
MEDIROM Group Reports Q1 2026 Results
29/05/2026
TOKYO, May 28, 2026 (GLOBE NEWSWIRE) -- This report presents an overview of our business performance and key performance indicators (KPIs) for the first quarter of 2026 (January–March 2026). It also highlights trends [...]
New Research from ATI Advisory Finds I-SNP Enrollment Associated with Better Outcomes for Long-Term Care Residents
29/05/2026
ATI Advisory study, supported by AHCA/NCAL, shows correlation between I-SNP enrollment and lower rates of hospitalization, emergency department visits, and mortality among nursing facility residents Washington, DC, May [...]
Intuitive Announces New Chief Commercial and Marketing Officer Taylor Patton
28/05/2026
Current Chief Commercial and Marketing Officer Henry Charlton to become SVP of Global Business Operations SUNNYVALE, Calif., May 28, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in [...]
Keeps TRT Claims Evaluated: Clinician-Prescribed Testosterone Replacement Therapy Medication Online
28/05/2026
Compounded Testosterone Medication, Injectable TRT, Oral TRT, Enclomiphene Off-Label, Lab Panel, FDA Status, Pricing, and Telehealth Prescribing Rules (2026) New York, NY, May 28, 2026 (GLOBE NEWSWIRE) -- Compounded [...]
Allogene Therapeutics Announces Planned CEO Succession
28/05/2026
David Chang, M.D., Ph.D., to Transition from President and Chief Executive Officer Following Eight Years of Outstanding Leadership and Continue to Serve on the Board of Directors Zachary Roberts, M.D., Ph.D., EVP, [...]

Pages